Gene-Cell Presents Novel Microinjection and Gene Modification Technologies at London Transgenics Conference; Outlines Inventions and Patents Filed for Two Significant Advances in Genetic Medicine LONDON, Sept. 18, 2001 (PRIMEZONE) -- Brian R. Davis, Ph.D., President and CEO of Gene-Cell, Inc., (OTCBB:GCLL) a leading research and development company devoted to non-viral methods of targeted...